Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), Symporters inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H23ClKN6O |
InChIKeyFDKIDFYIEWFERB-UHFFFAOYSA-N |
CAS Registry124750-99-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypertension | Phase 3 | BR | 27 Nov 2019 |